	Solasonine suppresses non-small cell lung cancer progression by inhibiting the STAT3/PD-L1 axis. Sci Rep Zheng L, Song Q, Liang J. PMID: 42230729 [PubMed - as supplied by publisher]
	The application of rapid ultrasound-guided paraffin technique in the pathological examination of biopsy specimens from non-small cell lung cancer. Sci Rep Zhu LH, Yang JR, Xia WX, Qiu YL, Ye XZ, Qi XF. PMID: 42230693 [PubMed - as supplied by publisher]
	Lipid Metabolic Reprogramming in Lung Cancer: Mechanisms and Therapeutic Targets in the Tumor Microenvironment. Int J Cancer Wang S, Yu J. PMID: 42230155 [PubMed - as supplied by publisher]
	Machine learning assessment of pathologic response in lung cancer resections after neoadjuvant therapy - IASLC MPR Project. J Thorac Oncol Dacic S, Shenker D, Redman M, Brunner L, Saqi A, Cooper WA, Borczuk A, Chung JH, Glass C, Lopez JM, Roden AC, Sholl L, Weissferdt A, Brosnan-Cashman J, Hennek S, Grullon S, Posadas J, Fujimoto J, Connolly C, Wynes MW, Sanchez-Espiridion B, Lee JJ, Berezowska S, Chou TY, Kerr K, Nicholson AG, Schalper KA, Tsao MS, Ready N, Cascone T, Heymach J, Sepesi B, Shu C, Rizvi N, Sonett J, Altorki N, Provencio M, Bunn PA Jr, Kris MG, Travis W, Yu L, Wistuba I, IASLC Pathology Committee. PMID: 42229633 [PubMed - as supplied by publisher]
	Comparative efficacy of tarlatamab and second-line therapies in extensive-stage small cell lung cancer: A network meta-analysis. Lung Cancer Wang J, Takundwa R, Yang H, Chai X, Yu Y, Zhang Y, Dirnberger F, Anderson ES, Pastel M, Pundole X, Gomez-Randulfe I, Blackhall F. PMID: 42229339 [PubMed - as supplied by publisher]
	Cardiovascular adverse events in non-small cell lung cancer patients receiving osimertinib therapy: a systematic review and meta-analysis. Lung Cancer Liu WH, Cheng YJ, Kang J, Chen J, An ZJ, Li TH, Tan N, Zhong WZ, Wu YL, Jiang L. PMID: 42229338 [PubMed - as supplied by publisher]
	Impact of adjuvant breast radiotherapy on the risk and the survival of second primary lung cancer: a large population-based study. Jpn J Clin Oncol Ji NN, Yang XY, Xiao SQ, Zhao N, Su WL, Xu JN, Shao L, Li SN, Zeng YC. PMID: 42228854 [PubMed - as supplied by publisher]
	Fibroblast activation protein inhibitor-PET/CT in lung cancer: a prospective single-center study with histopathological correlation of fibroblast activation protein expression. Int J Clin Oncol Hiroshima T, Kimura T, Watabe T, Matsui T, Omura A, Sugiura Y, Nagata H, Kimura K, Fukui E, Kanou T, Ose N, Tatsumi M, Giesel FL, Morii E, Shintani Y. PMID: 42228299 [PubMed - as supplied by publisher]
	Prognostic impact of weight loss during first-line chemotherapy in extensive-disease small cell lung cancer. Support Care Cancer Fujisaki T, Naito T, Kumaki S, Kataoka S, Saito S, Matsuda S, Kobayashi H, Ko R, Wakuda K, Ono A, Murakami H, Takahashi T, Kenmotsu H. PMID: 42228208 [PubMed - indexed for MEDLINE]
	Implementing an Evidence-Based Smoking Cessation Referral Tool Kit in a High-Risk Lung Cancer Screening Clinic. Clin J Oncol Nurs Mathey K, Von Ah D. PMID: 42227788 [PubMed - in process]
	Clinical Utility of Comprehensive Genomic Profiling for Advanced Non-Small Cell Lung Cancer: A Single-Center Retrospective Study. Thorac Cancer Murakami S, Hiroshima Y, Katakura S, Kondo T, Kato T, Yokose T, Saito H. PMID: 42227590 [PubMed - in process]
	Unveiling the Mechanisms of Liujunzi Decoction in COVID-19/Lung Cancer Comorbidity: A Network Pharmacology and Molecular Docking Study. Curr Pharm Des Yang P, Li Q, Zuo J, Chu T, Shu X, Shu P. PMID: 42227389 [PubMed - as supplied by publisher]
	Diagnostic pathways for lung cancer patients in Denmark: General practice events, first referral and stage at diagnosis. Acta Oncol Jarbøl DE, Haastrup P, Rasmussen S, Lauridsen GB, Balasubramaniam K, Ahrenfeldt LJ, Lykkegaard J, Sætre LMS. PMID: 42227152 [PubMed - in process]
	Solitary Parotid Metastasis as an Atypical Site of Recurrence in Lung Squamous Cell Carcinoma: A Diagnostic Difficulty. Cureus Prateaux MA, Haouane MA, Rharrassi I, Azami MA. PMID: 42226864 [PubMed]
	Anlotinib Plus Immune Checkpoint Inhibitors versus Chemotherapy in Elderly Patients with Extensive-Stage Small-Cell Lung Cancer: A Real World, Exploratory Study. Drug Des Devel Ther Lu BW, Zhao C, Wang DZ, Wang W. PMID: 42226757 [PubMed - in process]
	Welding and brazing fumes and lung cancer risk: a systematic review and meta-analysis. J Occup Med Toxicol Kim Y, Kim EM, Kim I. PMID: 42226199 [PubMed]
	Construction of a nomogram model for postoperative complications following thoracoscopic lung cancer surgery in elderly patients: a study based on an elderly patient population. BMC Geriatr Ma S, Du H, Li F, Bu L, Wang L. PMID: 42226137 [PubMed - as supplied by publisher]
	Mapping the antibody-drug-conjugates landscape in non-small cell lung cancer: Where are we and where are we going? Cancer Parisi C, Barlesi F, Planchard D. PMID: 42226007 [PubMed - in process]
	The future promise of antibody-drug conjugates in extensive-stage small cell lung cancer. Cancer Sethakorn N, Chiang AC. PMID: 42226003 [PubMed - indexed for MEDLINE]
	SEZ6-targeting antibody-drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial. Nat Med Byers LA, Cho BC, Cooper AJ, Chiang AC, Han JY, Furqan M, Dowlati A, Morgensztern D, Papadopoulos KP, Choudhury NJ, Vieito M, Bar J, Kim JH, Akerley W, Kim TM, Kim YC, Paz-Ares L, Ahn MJ, Yokouchi H, Meiman D, Munasinghe W, Ogunyankin O, Jahchan N, Wang S, Ferlini C, Robinson RR, Kohlhapp FJ, Palenski T, Rivell G, Hingorani P, Chandana S. PMID: 42225988 [PubMed - as supplied by publisher]

Articles 1 - 20 / 159172

Page 1 of 7959



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy